Using artificial intelligence and machine learning, a team of researchers engineered an enzyme to degrade toxic PFAS molecules — and they’re only in high school.
Synthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods.
Engineered peptides that mimic molecules of the innate immune system act synergistically with available drugs to treat Candida albicans in an animal model.
By engineering cells to translate quadruplet codons instead of the standard triplets, scientists expand the possible amino acids that can be integrated into proteins, paving the way for novel protein-based therapeutics and research tools.
Cell membranes act as containers for cell contents. Synthetic cells need them too. Researchers developed a new vessel that uses an unusual border: actin.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?